StockData

China SXT Pharmaceuticals, Inc. (SXTC) stock

SXTCNasdaqPharmaceutical PreparationsFiscal year ends March 31
Financials through fiscal 2026, year ended Mar 31, 2026Last filing: 20-F on Jul 1, 2026Score 4/30
$2.83−0.03 (-1.05%)

Close on Nov 18, 2026Market cap $2.71MP/E –Yield –

China SXT Pharmaceuticals net income

Net income is the profit left for shareholders after every expense, interest and tax.

For fiscal 2026 it was -$6.21M. The highest annual figure on record is $1.54M in fiscal 2019.

Annual net income

PeriodPeriod endValueChange
FY2026Mar 31, 2026-$6.21M–
FY2025Mar 31, 2025-$3.30M–
FY2024Mar 31, 2024-$3.10M–
FY2023Mar 31, 2023-$5.93M–
FY2022Mar 31, 2022-$5.74M–
FY2021Mar 31, 2021-$2.75M–
FY2020Mar 31, 2020-$10.29M-768.4%
FY2019Mar 31, 2019$1.54M+29.6%
FY2018Mar 31, 2018$1.19M+0.2%
FY2017Mar 31, 2017$1.19M–

More China SXT Pharmaceuticals figures

See a number that looks wrong?